Skip to main content
Proceedings (Baylor University. Medical Center) logoLink to Proceedings (Baylor University. Medical Center)
. 2006 Jul;19(3):277–278. doi: 10.1080/08998280.2006.11928179

Bumps on the hand

Jennifer Clay Cather 1,
PMCID: PMC1484538  PMID: 17252048

A young girl presented with flesh-colored lesions on her hands that were increasing in size and number (Figures 1 and 2). There were no associated symptoms.

Figure 1.

Figure 1

Numerous flesh-colored lesions on the dorsal hand.

Figure 2.

Figure 2

Dome-shaped papules on bilateral fifth fingers.

What is your diagnosis?

DIAGNOSIS: This patient has two unrelated cutaneous lesions: verrucae (Figure 1) and rudimentary ulnar supernumerary digits (Figure 2). For both lesions, the diagnosis is based primarily on history and clinical findings.

DISCUSSION

There are numerous human papillomavirus(HPV) serotypes that cause a myriad of cutaneous lesions (1), most of which are benign but some of which are malignant. Most commonly, verrucae on the hand are flesh-colored exophytic verrucous papules associated with serotypes HPV-1, -2, -3, -4, -7, and -10. Trauma may spread lesions. Individual lesions oftentimes have minute punctate black dots, which represent thrombosed blood vessels. This clinical finding is an important distinguishing sign that aids in differentiating a verruca from a callus, which has a clear center.

The lesions in 2 are smooth-domed papules present bilaterally on the fifth digits. These lesions were congenital and are most consistent with rudimentary supernumerary digits. Rudimentary supernumerary digits are usually asymptomatic and typically occur at the base of the fifth digit on the ulnar side. While the exact etiology is unknown, these lesions are presumed to represent autoamputation or postnatal destruction of a supernumerary digit (2).

Treatment

Rudimentary supernumerary digits require no therapy. In contrast, therapeutic options for verrucae are numerous and are aimed primarily at local destruction and an increased host response to the viral infection (Table). The most common therapy in adults is cryosurgery with liquid nitrogen. Young children benefit from a less traumatic intervention such as over-the-counter topical salicylic acid preparations (e.g., Compound W, Occlusal, Sal-Acid, Wart-Off, DuoFilm, Dr. Scholl's Clear Away, Trans-Ver-Sal, or Mediplast), topical imiquimod (off label), or Cantharone. Usually numerous office visits are required to treat even one wart, and the number of visits required for patients with compromised immune systems (i.e., children, transplant patients, or AIDS patients) is even greater.

Table.

Therapeutic options for verrucae

Type Examples
Destructive Cantharone
Cryosurgery
Electrosurgery
Laser (vaporization or pulse dye)
Trichloroacetic acid

Immune-modulating Intralesional bleomycin
Intralesional injections (Candida, Trichophyton, or mumps antigen) (5)
Intralesional interferon
Cidofovir (6)
Imiquimod cream 5% (7)
Retinoids (systemic or topical)
Vaccines (investigational)

∗Options described in references 3 and 4, except as noted.

Because repeat visits and procedures are expensive and the procedures can be painful, some authors have reported on the utility of duct tape in removing warts (8). While this is a controversial therapy, the risks are minimal. If patients choose this option, the best results are obtained when they apply a salicylic acid over-the-counter preparation to the verruca and then apply duct tape over the affected area. The duct tape is left on for a week and then the above regimen is repeated until the lesions are gone. Usually an 8-week trial is necessary to see therapeutic benefit.

References

  • 1.Akgul B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol. 2006;208(2):165–175. doi: 10.1002/path.1893. [DOI] [PubMed] [Google Scholar]
  • 2.Shapiro L, Juhlin EA, Brownstein MH. “Rudimentary polydactyly”: an amputation neuroma. Arch Dermatol. 1973;108(2):223–225. [PubMed] [Google Scholar]
  • 3.Miller DM, Brodell RT. Human papillomavirus infection: treatment options for warts. Am Fam Physician. 1996;53(1):135–143. 148–150. [PubMed] [Google Scholar]
  • 4.Leman JA, Benton EC. Verrucas. Guidelines for management. Am J Clin Dermatol. 2000;1(3):143–149. doi: 10.2165/00128071-200001030-00001. [DOI] [PubMed] [Google Scholar]
  • 5.Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141(5):589–594. doi: 10.1001/archderm.141.5.589. [DOI] [PubMed] [Google Scholar]
  • 6.Toro JR, Sanchez S, Turiansky G, Blauvelt A. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox. Dermatol Clin. 2003;21(2):301–309. doi: 10.1016/s0733-8635(02)00116-x. [DOI] [PubMed] [Google Scholar]
  • 7.Brown VL, Atkins CL, Ghali L, Cerio R, Harwood CA, Proby CM. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol. 2005;141(8):985–993. doi: 10.1001/archderm.141.8.985. [DOI] [PubMed] [Google Scholar]
  • 8.Lynch TJ. Duct tape removes warts. J Fam Pract. 2003;52(2):111–112. [PubMed] [Google Scholar]

Articles from Proceedings (Baylor University. Medical Center) are provided here courtesy of Baylor University Medical Center

RESOURCES